Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+62.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $34.40M | +14.2% |
| 2024 | $30.13M | +141.4% |
| 2023 | $12.48M | +55.9% |
| 2022 | $8.01M | +30.2% |
| 2021 | $6.15M | - |